Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIZE: Benralizumab effect on flu vaccine response in asthma
NCT02814643Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2016
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Jul 2016; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02814643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814643.